Or is there a vaccine deal with just a few numbers? The reality is encouraged again.
Date 08 Feb 2021 time 21:03
–
Although many countries have entered into agreements to purchase the COVID-19 vaccine, Either through direct contact with the manufacturer or through participating in an international program, but faced with the problem of having a vaccine not meeting the deal.
1. Because the vaccine against COVID-19 Is in demand all over the world As a result, vaccines are currently in short supply and many countries are not getting vaccines as previously agreed upon.
2. Even the countries participating in the COVAX program, which is a vaccine allocation program for over 150 countries around the world to get the fair vaccination, faced this problem. In principle, COVAX is that wealthy countries donate vaccine payments to poor countries with no purchasing power. To distribute vaccines to risk groups in each country equally and fairly.
3. But in practice, wealthy countries, as well as those with relatively low purchasing power, have turned to deals with vaccine manufacturers to get vaccines at different prices and times that are negotiable. Wax, which has more conditions The vaccine to fall to the covax program is relatively rare, according to Nature, the US scientific journal, that some poor-income countries may have to wait at least until 2022 to get the vaccine.
4. Not only will the deal outside of the cowax program result in fewer vaccines entering the program. But even participating countries have yet to comply with the agreement, such as Canada, which is a cowax member, has violated the agreement.
5. By Canada, which ordered 414 million doses of the vaccine, five times the number required by the entire population. And most recently it has agreed to receive nearly 1.9 million doses of the vaccine from cowax by the end of June. Create dissatisfaction with member states as it will adversely affect the poorer countries.
6. Just like Germany, it has 30 million vaccine deals from vaccine companies outside of the Common EU mechanism. This creates a great dissatisfaction to EU countries. Ultimately, the European Commission has called on Germany to deliver the vaccine only after the joint EU order has been completed.
7.The EU has bought and stocked the vaccine, ordering nearly 2.3 billion doses of the vaccine from six manufacturers, while the population is just 450 million.
8. Nigeria, which announced in January it would receive 100,000 doses of Pfizer vaccine by February. Was postponed The World Health Organization (WHO) says that only four of the 13 African countries will be vaccinated through the covax program this time.
9. Tevodros Adhanom, director of the World Health Organization, said in January. “There are currently 39 million doses of vaccination in at least 49 high-income countries, while one poor country receives only 25 vaccines.” 25 million doses
10. There are also countries that have faced problems getting vaccines that do not meet agreements, such as in Switzerland. Immunizations have to be postponed to citizens like the Canton of Vaud by 6 weeks due to a delay in vaccine delivery. The EU has also faced a delay in receiving vaccines from AstraZeneca.
11. Delayed or non-compliance with the vaccine may not involve participation or not participating in the Cowax Program. Rather, it is because wealthy countries with massive purchasing and bargaining power have already hoarded vaccines. And joining the cowax project may not be the solution for Thailand.
Photo by ALAIN JOCARD / AFP
– .
